首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials
Authors:Francesco Rodeghiero  Roberto Stasi  Aristoteles Giagounidis  Jean‐François Viallard  Bertrand Godeau  Ingrid Pabinger  Douglas Cines  Howard Liebman  Xuena Wang  Paul Woodard
Affiliation:1. San Bortolo Hospital, , Vicenza, Italy;2. St. George's Healthcare NHS Trust, , London, UK;3. Marienhospital Düsseldorf, , Düsseldorf, Germany;4. H?pital du Haut Lévèque, University of Bordeaux 2, , Pessac, France;5. CHU Henri Mondor, , Créteil, France;6. Medical University of Vienna, , Vienna, Austria;7. Perelman School of Medicine, University of Pennsylvania, , Philadelphia, PA, USA;8. Keck School of Medicine, University of Southern California, , Los Angeles, CA, USA;9. Global Biomedical Data Sciences, Amgen Inc., , Thousand Oaks, CA, USA;10. Amgen Inc, , Thousand Oaks, CA, USA
Abstract:
Keywords:immune thrombocytopenia  review  adverse events  romiplostim
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号